Tess Cameron
Director of Finance/CFO at RESEARCH ALLIANCE CORP. II
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Peter Kolchinsky | M | 47 |
RA Capital Management LP (Private Equity)
 RA Capital Management LP (Private Equity) Investment ManagersFinance RA Capital Management LP (Private Equity) (RA Capital) is a private equity & venture capital subsidiary of RA Capital Management LP founded by Peter Kolchinsky in 2004. The firm is headquartered in Boston, MA. | 23 years |
| Matthew Hammond | M | 35 |
RA Capital Management LP (Private Equity)
RA Capital Management LP (Private Equity) Investment ManagersFinance RA Capital Management LP (Private Equity) (RA Capital) is a private equity & venture capital subsidiary of RA Capital Management LP founded by Peter Kolchinsky in 2004. The firm is headquartered in Boston, MA. | 10 years |
| Milind Deshpande | M | 67 |
Avilar Therapeutics, Inc.
 Avilar Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Avilar Therapeutics is an American biopharmaceutical company that specializes in the discovery and development of extracellular protein degraders. The company is based in an undisclosed location. The company has developed a proprietary discovery platform that includes novel, high-affinity, small molecule asgpr ligands and advanced modeling of the biophysics, pharmacokinetics, and pharmacodynamics of atac mediated endocytosis and degradation. Avilar is developing atacs, a new class of protein degraders that shuttle disease-causing proteins from circulation to the endolysosome where the unwanted proteins are degraded. The company is leveraging their atac platform to create a broad and diverse pipeline of first-in-class extracellular protein degraders. The company was founded by Nathaniel Brooks Horwitz and Jamie Kasuboski. The CEO is Daniel S. Grau.
RA Capital Management LP (Private Equity)
RA Capital Management LP (Private Equity) Investment ManagersFinance RA Capital Management LP (Private Equity) (RA Capital) is a private equity & venture capital subsidiary of RA Capital Management LP founded by Peter Kolchinsky in 2004. The firm is headquartered in Boston, MA. | 6 years |
| William Rhodes | M | 70 |
Nodexus, Inc.
 Nodexus, Inc. Miscellaneous Commercial ServicesCommercial Services Nodexus, Inc. operates as a biotechnology services platform. It provides research and diagnostics, drug discovery, cell line development, forensics, CRISPR, and animal vaccination. The company was founded by Karthik Balakrishnan and Anand Kesavarajuin 2014 and is headquartered in Hayward, CA. | 3 years |
| Vera Imper | M | 62 | 3 years | |
| Karthik Balakrishnan | M | - |
Nodexus, Inc.
Nodexus, Inc. Miscellaneous Commercial ServicesCommercial Services Nodexus, Inc. operates as a biotechnology services platform. It provides research and diagnostics, drug discovery, cell line development, forensics, CRISPR, and animal vaccination. The company was founded by Karthik Balakrishnan and Anand Kesavarajuin 2014 and is headquartered in Hayward, CA. | 10 years |
| Anand Kesavaraju | M | - |
Nodexus, Inc.
Nodexus, Inc. Miscellaneous Commercial ServicesCommercial Services Nodexus, Inc. operates as a biotechnology services platform. It provides research and diagnostics, drug discovery, cell line development, forensics, CRISPR, and animal vaccination. The company was founded by Karthik Balakrishnan and Anand Kesavarajuin 2014 and is headquartered in Hayward, CA. | 10 years |
| Reza Halse | M | 50 |
RA Capital Management LP (Private Equity)
RA Capital Management LP (Private Equity) Investment ManagersFinance RA Capital Management LP (Private Equity) (RA Capital) is a private equity & venture capital subsidiary of RA Capital Management LP founded by Peter Kolchinsky in 2004. The firm is headquartered in Boston, MA. | 3 years |
| Scott Biller | M | 68 | 4 years | |
| NATHANIEL BROOKS HORWITZ | M | - |
RA Capital Management LP (Private Equity)
RA Capital Management LP (Private Equity) Investment ManagersFinance RA Capital Management LP (Private Equity) (RA Capital) is a private equity & venture capital subsidiary of RA Capital Management LP founded by Peter Kolchinsky in 2004. The firm is headquartered in Boston, MA.
Avilar Therapeutics, Inc.
Avilar Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Avilar Therapeutics is an American biopharmaceutical company that specializes in the discovery and development of extracellular protein degraders. The company is based in an undisclosed location. The company has developed a proprietary discovery platform that includes novel, high-affinity, small molecule asgpr ligands and advanced modeling of the biophysics, pharmacokinetics, and pharmacodynamics of atac mediated endocytosis and degradation. Avilar is developing atacs, a new class of protein degraders that shuttle disease-causing proteins from circulation to the endolysosome where the unwanted proteins are degraded. The company is leveraging their atac platform to create a broad and diverse pipeline of first-in-class extracellular protein degraders. The company was founded by Nathaniel Brooks Horwitz and Jamie Kasuboski. The CEO is Daniel S. Grau. | 5 years |
| Donnie Hardison | M | 73 | 2 years | |
| Jamie Kasuboski | M | - |
Avilar Therapeutics, Inc.
Avilar Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Avilar Therapeutics is an American biopharmaceutical company that specializes in the discovery and development of extracellular protein degraders. The company is based in an undisclosed location. The company has developed a proprietary discovery platform that includes novel, high-affinity, small molecule asgpr ligands and advanced modeling of the biophysics, pharmacokinetics, and pharmacodynamics of atac mediated endocytosis and degradation. Avilar is developing atacs, a new class of protein degraders that shuttle disease-causing proteins from circulation to the endolysosome where the unwanted proteins are degraded. The company is leveraging their atac platform to create a broad and diverse pipeline of first-in-class extracellular protein degraders. The company was founded by Nathaniel Brooks Horwitz and Jamie Kasuboski. The CEO is Daniel S. Grau. | 5 years |
| Stephen Hoffman | M | 70 | 3 years | |
| Stephanie Tozzo | M | 62 |
Avilar Therapeutics, Inc.
Avilar Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Avilar Therapeutics is an American biopharmaceutical company that specializes in the discovery and development of extracellular protein degraders. The company is based in an undisclosed location. The company has developed a proprietary discovery platform that includes novel, high-affinity, small molecule asgpr ligands and advanced modeling of the biophysics, pharmacokinetics, and pharmacodynamics of atac mediated endocytosis and degradation. Avilar is developing atacs, a new class of protein degraders that shuttle disease-causing proteins from circulation to the endolysosome where the unwanted proteins are degraded. The company is leveraging their atac platform to create a broad and diverse pipeline of first-in-class extracellular protein degraders. The company was founded by Nathaniel Brooks Horwitz and Jamie Kasuboski. The CEO is Daniel S. Grau. | 3 years |
| Adrian Rawcliffe | M | 52 | 7 years | |
| Clive Patience | M | 60 | 4 years | |
| Thomas Leggett | M | 47 | 3 years | |
| I. Anita Anand | F | - |
University of Toronto
| 18 years |
| Emily Minkow | F | 41 |
RA Capital Management LP (Private Equity)
RA Capital Management LP (Private Equity) Investment ManagersFinance RA Capital Management LP (Private Equity) (RA Capital) is a private equity & venture capital subsidiary of RA Capital Management LP founded by Peter Kolchinsky in 2004. The firm is headquartered in Boston, MA. | 2 years |
| Cony D’Cruz | M | 62 |
RA Capital Management LP (Private Equity)
RA Capital Management LP (Private Equity) Investment ManagersFinance RA Capital Management LP (Private Equity) (RA Capital) is a private equity & venture capital subsidiary of RA Capital Management LP founded by Peter Kolchinsky in 2004. The firm is headquartered in Boston, MA. | - |
| Anita Anand | F | - |
University of Toronto
| 18 years |
| Joshua Resnick | M | - |
Avilar Therapeutics, Inc.
Avilar Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Avilar Therapeutics is an American biopharmaceutical company that specializes in the discovery and development of extracellular protein degraders. The company is based in an undisclosed location. The company has developed a proprietary discovery platform that includes novel, high-affinity, small molecule asgpr ligands and advanced modeling of the biophysics, pharmacokinetics, and pharmacodynamics of atac mediated endocytosis and degradation. Avilar is developing atacs, a new class of protein degraders that shuttle disease-causing proteins from circulation to the endolysosome where the unwanted proteins are degraded. The company is leveraging their atac platform to create a broad and diverse pipeline of first-in-class extracellular protein degraders. The company was founded by Nathaniel Brooks Horwitz and Jamie Kasuboski. The CEO is Daniel S. Grau. | - |
| Massimiliano Simi | M | - |
Medical Microinstruments SpA
 Medical Microinstruments SpA Medical SpecialtiesHealth Technology Medical Microinstruments SpA develops and manufactures surgical micro-instruments. The firm focuses on clinical outcomes for patients undergoing microsurgery, and offers advanced microsurgical procedures, while reducing costs for patients, hospitals and for society at large. The company was founded by Giuseppe Prisco, Hannah Teichmann and Massimiliano Simi in 2015 and is headquartered in Calci, Italy. | 9 years |
| Laura Tadvalkar | F | - |
RA Capital Management LP (Private Equity)
RA Capital Management LP (Private Equity) Investment ManagersFinance RA Capital Management LP (Private Equity) (RA Capital) is a private equity & venture capital subsidiary of RA Capital Management LP founded by Peter Kolchinsky in 2004. The firm is headquartered in Boston, MA. | 4 years |
| Marty Freed | M | - |
Avilar Therapeutics, Inc.
Avilar Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Avilar Therapeutics is an American biopharmaceutical company that specializes in the discovery and development of extracellular protein degraders. The company is based in an undisclosed location. The company has developed a proprietary discovery platform that includes novel, high-affinity, small molecule asgpr ligands and advanced modeling of the biophysics, pharmacokinetics, and pharmacodynamics of atac mediated endocytosis and degradation. Avilar is developing atacs, a new class of protein degraders that shuttle disease-causing proteins from circulation to the endolysosome where the unwanted proteins are degraded. The company is leveraging their atac platform to create a broad and diverse pipeline of first-in-class extracellular protein degraders. The company was founded by Nathaniel Brooks Horwitz and Jamie Kasuboski. The CEO is Daniel S. Grau. | - |
| Cosmas Giallourakis | M | - |
RA Capital Management LP (Private Equity)
RA Capital Management LP (Private Equity) Investment ManagersFinance RA Capital Management LP (Private Equity) (RA Capital) is a private equity & venture capital subsidiary of RA Capital Management LP founded by Peter Kolchinsky in 2004. The firm is headquartered in Boston, MA. | 3 years |
| Dan Marks | M | - |
RA Capital Management LP (Private Equity)
RA Capital Management LP (Private Equity) Investment ManagersFinance RA Capital Management LP (Private Equity) (RA Capital) is a private equity & venture capital subsidiary of RA Capital Management LP founded by Peter Kolchinsky in 2004. The firm is headquartered in Boston, MA. | 2 years |
| Jack Vailas | M | - |
RA Capital Management LP (Private Equity)
RA Capital Management LP (Private Equity) Investment ManagersFinance RA Capital Management LP (Private Equity) (RA Capital) is a private equity & venture capital subsidiary of RA Capital Management LP founded by Peter Kolchinsky in 2004. The firm is headquartered in Boston, MA. | 3 years |
| Chaim Goldreich | M | 58 |
University of Toronto
| 19 years |
| Andrew Germain | M | - | 4 years | |
| Carlo Alberto Marcoaldi | M | - |
Medical Microinstruments SpA
Medical Microinstruments SpA Medical SpecialtiesHealth Technology Medical Microinstruments SpA develops and manufactures surgical micro-instruments. The firm focuses on clinical outcomes for patients undergoing microsurgery, and offers advanced microsurgical procedures, while reducing costs for patients, hospitals and for society at large. The company was founded by Giuseppe Prisco, Hannah Teichmann and Massimiliano Simi in 2015 and is headquartered in Calci, Italy. | - |
| Ryan Rhodes | M | - |
Medical Microinstruments SpA
Medical Microinstruments SpA Medical SpecialtiesHealth Technology Medical Microinstruments SpA develops and manufactures surgical micro-instruments. The firm focuses on clinical outcomes for patients undergoing microsurgery, and offers advanced microsurgical procedures, while reducing costs for patients, hospitals and for society at large. The company was founded by Giuseppe Prisco, Hannah Teichmann and Massimiliano Simi in 2015 and is headquartered in Calci, Italy. | 4 years |
| Hannah Teichmann | F | - |
Medical Microinstruments SpA
Medical Microinstruments SpA Medical SpecialtiesHealth Technology Medical Microinstruments SpA develops and manufactures surgical micro-instruments. The firm focuses on clinical outcomes for patients undergoing microsurgery, and offers advanced microsurgical procedures, while reducing costs for patients, hospitals and for society at large. The company was founded by Giuseppe Prisco, Hannah Teichmann and Massimiliano Simi in 2015 and is headquartered in Calci, Italy. | 9 years |
| Joshua Resnick | M | 49 |
RA Capital Management LP (Private Equity)
RA Capital Management LP (Private Equity) Investment ManagersFinance RA Capital Management LP (Private Equity) (RA Capital) is a private equity & venture capital subsidiary of RA Capital Management LP founded by Peter Kolchinsky in 2004. The firm is headquartered in Boston, MA. | 6 years |
| Risa Stack | M | 55 |
RA Capital Management LP (Private Equity)
RA Capital Management LP (Private Equity) Investment ManagersFinance RA Capital Management LP (Private Equity) (RA Capital) is a private equity & venture capital subsidiary of RA Capital Management LP founded by Peter Kolchinsky in 2004. The firm is headquartered in Boston, MA. | - |
| Andrew Cleeland | M | - |
Medical Microinstruments SpA
Medical Microinstruments SpA Medical SpecialtiesHealth Technology Medical Microinstruments SpA develops and manufactures surgical micro-instruments. The firm focuses on clinical outcomes for patients undergoing microsurgery, and offers advanced microsurgical procedures, while reducing costs for patients, hospitals and for society at large. The company was founded by Giuseppe Prisco, Hannah Teichmann and Massimiliano Simi in 2015 and is headquartered in Calci, Italy. | 4 years |
| Catherine J. Riggall | F | - |
University of Toronto
| 20 years |
| Raj Shah | M | 46 |
RA Capital Management LP (Private Equity)
RA Capital Management LP (Private Equity) Investment ManagersFinance RA Capital Management LP (Private Equity) (RA Capital) is a private equity & venture capital subsidiary of RA Capital Management LP founded by Peter Kolchinsky in 2004. The firm is headquartered in Boston, MA. | 20 years |
| Cristina H. Amon | M | 67 |
University of Toronto
| 18 years |
| Arturo Baroncelli | M | - |
Medical Microinstruments SpA
Medical Microinstruments SpA Medical SpecialtiesHealth Technology Medical Microinstruments SpA develops and manufactures surgical micro-instruments. The firm focuses on clinical outcomes for patients undergoing microsurgery, and offers advanced microsurgical procedures, while reducing costs for patients, hospitals and for society at large. The company was founded by Giuseppe Prisco, Hannah Teichmann and Massimiliano Simi in 2015 and is headquartered in Calci, Italy. | 2 years |
| Adam Rosenberg | M | 54 |
RA Capital Management LP (Private Equity)
RA Capital Management LP (Private Equity) Investment ManagersFinance RA Capital Management LP (Private Equity) (RA Capital) is a private equity & venture capital subsidiary of RA Capital Management LP founded by Peter Kolchinsky in 2004. The firm is headquartered in Boston, MA. | 4 years |
| Andrew Levin | M | 47 |
RA Capital Management LP (Private Equity)
RA Capital Management LP (Private Equity) Investment ManagersFinance RA Capital Management LP (Private Equity) (RA Capital) is a private equity & venture capital subsidiary of RA Capital Management LP founded by Peter Kolchinsky in 2004. The firm is headquartered in Boston, MA. | 9 years |
| Thomas Hudson | M | 62 |
University of Toronto
| 17 years |
| Sadik Kassim | M | - |
RA Capital Management LP (Private Equity)
RA Capital Management LP (Private Equity) Investment ManagersFinance RA Capital Management LP (Private Equity) (RA Capital) is a private equity & venture capital subsidiary of RA Capital Management LP founded by Peter Kolchinsky in 2004. The firm is headquartered in Boston, MA. | - |
| Andrew ElBardissi | M | 42 |
Medical Microinstruments SpA
Medical Microinstruments SpA Medical SpecialtiesHealth Technology Medical Microinstruments SpA develops and manufactures surgical micro-instruments. The firm focuses on clinical outcomes for patients undergoing microsurgery, and offers advanced microsurgical procedures, while reducing costs for patients, hospitals and for society at large. The company was founded by Giuseppe Prisco, Hannah Teichmann and Massimiliano Simi in 2015 and is headquartered in Calci, Italy. | 2 years |
| Anurag Kondapalli | M | - |
RA Capital Management LP (Private Equity)
RA Capital Management LP (Private Equity) Investment ManagersFinance RA Capital Management LP (Private Equity) (RA Capital) is a private equity & venture capital subsidiary of RA Capital Management LP founded by Peter Kolchinsky in 2004. The firm is headquartered in Boston, MA. | 3 years |
| Ramin Farzaneh-Far | M | 47 |
RA Capital Management LP (Private Equity)
RA Capital Management LP (Private Equity) Investment ManagersFinance RA Capital Management LP (Private Equity) (RA Capital) is a private equity & venture capital subsidiary of RA Capital Management LP founded by Peter Kolchinsky in 2004. The firm is headquartered in Boston, MA. | 4 years |
| Joel C. Barrish | M | - |
RA Capital Management LP (Private Equity)
RA Capital Management LP (Private Equity) Investment ManagersFinance RA Capital Management LP (Private Equity) (RA Capital) is a private equity & venture capital subsidiary of RA Capital Management LP founded by Peter Kolchinsky in 2004. The firm is headquartered in Boston, MA. | 2 years |
| Mark Toland | M | 55 |
Medical Microinstruments SpA
Medical Microinstruments SpA Medical SpecialtiesHealth Technology Medical Microinstruments SpA develops and manufactures surgical micro-instruments. The firm focuses on clinical outcomes for patients undergoing microsurgery, and offers advanced microsurgical procedures, while reducing costs for patients, hospitals and for society at large. The company was founded by Giuseppe Prisco, Hannah Teichmann and Massimiliano Simi in 2015 and is headquartered in Calci, Italy. | 3 years |
| Derek DiRocco | M | 43 |
RA Capital Management LP (Private Equity)
RA Capital Management LP (Private Equity) Investment ManagersFinance RA Capital Management LP (Private Equity) (RA Capital) is a private equity & venture capital subsidiary of RA Capital Management LP founded by Peter Kolchinsky in 2004. The firm is headquartered in Boston, MA. | - |
| Jake Simson | M | 38 |
RA Capital Management LP (Private Equity)
RA Capital Management LP (Private Equity) Investment ManagersFinance RA Capital Management LP (Private Equity) (RA Capital) is a private equity & venture capital subsidiary of RA Capital Management LP founded by Peter Kolchinsky in 2004. The firm is headquartered in Boston, MA. | 7 years |
| Michael Cloonan | M | 53 |
RA Capital Management LP (Private Equity)
RA Capital Management LP (Private Equity) Investment ManagersFinance RA Capital Management LP (Private Equity) (RA Capital) is a private equity & venture capital subsidiary of RA Capital Management LP founded by Peter Kolchinsky in 2004. The firm is headquartered in Boston, MA. | - |
| Zach Scheiner | M | 47 |
RA Capital Management LP (Private Equity)
RA Capital Management LP (Private Equity) Investment ManagersFinance RA Capital Management LP (Private Equity) (RA Capital) is a private equity & venture capital subsidiary of RA Capital Management LP founded by Peter Kolchinsky in 2004. The firm is headquartered in Boston, MA. | 7 years |
| Prithviraj Roy | M | - |
RA Capital Management LP (Private Equity)
RA Capital Management LP (Private Equity) Investment ManagersFinance RA Capital Management LP (Private Equity) (RA Capital) is a private equity & venture capital subsidiary of RA Capital Management LP founded by Peter Kolchinsky in 2004. The firm is headquartered in Boston, MA. | 2 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Takeshi Wada | M | 63 | 5 years | |
| Eric Ng | M | - |
University of Toronto
| 7 years |
| Kamyar Hazaveh | M | - |
University of Toronto
| 4 years |
| Stefan Ioannou | M | - |
University of Toronto
| 10 years |
| Tom Keefe | M | - |
University of Toronto
| 5 years |
| Andrzej Jankowski | M | - |
University of Toronto
| 9 years |
| Yakun Liu | M | - |
University of Toronto
| 6 years |
| Ka Ho Yu | M | 44 |
University of Toronto
| 7 years |
| Yousef Rehman | M | 42 |
University of Toronto
| 7 years |
| Feng Deng | M | 61 | 4 years | |
| Brendan Cochrane | M | - |
University of Toronto
| 7 years |
| David Gaiero | M | 45 | 3 years | |
| Ricky Mehra | M | 45 |
University of Toronto
| 7 years |
| Florin Predescu VasvarI | M | 45 |
University of Toronto
| 5 years |
| Joseph Mocanu | M | - |
University of Toronto
| 5 years |
| David Toffoli | M | - |
University of Toronto
| 4 years |
| Nicholas Wood | M | - |
University of Toronto
| 6 years |
| Hui Wang | M | 44 |
University of Toronto
| 5 years |
| Zachary Newton | M | 40 |
University of Toronto
| 4 years |
| Marko Aleksic | M | - |
University of Toronto
| 7 years |
| Ryan Q. Fang | M | - |
University of Toronto
| 5 years |
| Adam Cilio | M | - |
University of Toronto
| 6 years |
| Meny Grauman | M | - |
University of Toronto
| 6 years |
| Rusty Wong | M | - |
University of Toronto
| 6 years |
| Masaharu Tanaka | M | 71 | 3 years | |
| Michael Dolega | M | - |
University of Toronto
| 7 years |
| Grant Connor | M | - |
University of Toronto
| 4 years |
| Shawn Siddiqui | M | - |
University of Toronto
| 7 years |
| Claudia Krywiak | M | - |
University of Toronto
| 3 years |
| Yuri Sagalov | M | - |
University of Toronto
| 5 years |
| Alfred C. Sum | M | - |
University of Toronto
| 6 years |
| Hussein Sunderji | M | - |
University of Toronto
| 9 years |
| Tom Rand | M | - |
University of Toronto
| 5 years |
| Peter Van Michaels | M | - |
University of Toronto
| 7 years |
| Bryan Edwin Rock | M | 45 |
University of Toronto
| 7 years |
| Krystal Nagel | F | - |
University of Toronto
| 4 years |
| Zixuan Hu | M | 36 |
University of Toronto
| 4 years |
| Jennifer McGoey | F | - |
University of Toronto
| 4 years |
| Tian Hai Lin | M | 37 |
University of Toronto
| 4 years |
| Megan Lindhe | F | - |
University of Toronto
| 2 years |
| Ani Kirakosyan | F | - |
University of Toronto
| 4 years |
| Fadi Ghazi | M | - |
University of Toronto
| 4 years |
| Jonathan Lau | M | - |
University of Toronto
| 1 years |
| Nigel D'Souza | M | - |
University of Toronto
| 5 years |
| Tina Hsiao | F | - |
University of Toronto
| 4 years |
| Alina Islam | F | - |
University of Toronto
| 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Canada | 48 | 48.00% |
| United States | 40 | 40.00% |
| Italy | 8 | 8.00% |
| Singapore | 4 | 4.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Tess Cameron
- Personal Network
